SMN2 and amyotrophic lateral sclerosis: Based on our data with BirA-SMN and BirA-SMNST, we envision that other pathology-associated mutants (e.g., FUS or TDP-43 mutants found in ALS) will be invaluable in a proteomic context to dissect molecularly neurodegenerative disorders.